Top Line: BVI has announced the launch of Serenity and Serenity Toric premium monofocal IOLs, the second generation of BVI’s Isopure family.
Close Up: These non-diffractive, aspheric IOLs use patented Isofocal optic technology to balance depth of focus and image quality, providing far vision equal to a monofocal but with good intermediate vision up to 66cm, BVI said. According to BVI, The Serenity series maintains the simplicity of a monofocal IOL while incorporating Isofocal technology to deliver spherical aberration correction across the entire optic diameter and customize the level of spherical aberration per dioptric power. In addition, the Serentiy Toric model benefits from the maneuverability of the double C-loop POD platform, which is exclusive to BVI and allows the IOL to be rotated clockwise or counterclockwise to align the cylinder with the axis. For astigmatic patients, the POD platform delivers a toric IOL that remains stable in the capsular bag, with outcomes accurately predicted by BVI’s toric calculator, said BVI.
Sheraz Daya MD FACP, FACS, FRCS(Ed), FRCOphth (Centre For Sight, UK), one of the first surgeons to implant Serenity, said, “It is wonderful to see this Increased range of focus lens (IROF) on the same platform as the Finevision with 4 C loop haptics. I look forward to the Toric version as well which I know will be very stable with no rotation.”
Shervin Korangy, president and CEO of BVI, said, “As we launch the second-generation SERENITY and SERENITY Toric IOLs, BVI views this IOL as potentially a game-changer when it comes to standard of care for monofocal procedures. Our portfolio includes a wide range of IOLs, meticulously designed from material to haptics to optics to provide the optimal outcome without the burden of retrofitting legacy predicate devices.”
Vital Stats: Serenity and Serenity Toric will have full commercial availability in CE-accepting markets in 2025.
www.bvimedical.com/us